The 2026 Patient’s Guide: Medical Cannabis and Firearm Rights in Massachusetts
At Elevate Care NP, we are committed to providing our patients with the most accurate and current information. A frequent question we encounter is whether a patient can legally hold both a Massachusetts medical cannabis card and a License to Carry (LTC).
While the Commonwealth provides robust protections for patients, the federal government maintains a strict, opposing stance. Here is what the law says today.
The Massachusetts State View: Protection of Rights
In Massachusetts, medical cannabis is treated as a protected healthcare choice. Under M.G.L. c. 94I, the state explicitly shields registered patients from being denied any "right or privilege" solely because of their medical cannabis use.
No Automatic Denial: There is no state statute that automatically disqualifies a medical cardholder from obtaining an LTC or FID.
The Suitability Factor: Under M.G.L. c. 140, § 131, local licensing authorities (Police Chiefs) have the discretion to determine if an applicant is a "suitable person." While most departments respect state medical protections, some may still use federal guidelines to question suitability.
Carrying While Impaired: This is a hard line. Under M.G.L. c. 269, § 10H, it is a criminal offense to carry a loaded firearm while under the influence of any controlled substance, including cannabis.
The Federal Conflict: "Unlawful User" Status
Despite state-level legality, the federal government currently classifies all cannabis users as "prohibited persons." Under 18 U.S.C. § 922(g)(3), it is a federal felony for an "unlawful user" of a controlled substance to possess a firearm or ammunition.
The ATF Form 4473: When purchasing a firearm from a federally licensed dealer (FFL), you must fill out Form 4473. Question 21(f) explicitly warns that marijuana remains unlawful under federal law regardless of state medical or recreational status.
The Paperwork Dilemma: Admitting to cannabis use results in an immediate denial of the sale. Denying use while holding a medical card is considered a federal felony (making a false statement on a federal document).
Will Rescheduling to Schedule III Solve This?
On April 22, 2026, the federal landscape shifted dramatically. Acting Attorney General Todd Blanche signed a final order officially reclassifying state-licensed medical marijuana as a Schedule III substance. While this is a landmark recognition of cannabis’s medical value, for firearm owners, the "victory" comes with a significant asterisk.
1. The "Prescription" vs. "Recommendation" Gap Rescheduling to Schedule III aligns cannabis with drugs like Tylenol with Codeine, which are legal to possess with a federal prescription. However, the FDA has not yet approved the cannabis plant itself as a prescription drug. Because your Massachusetts medical card is a "clinical recommendation" and not a federal prescription filled at a standard pharmacy, the ATF’s current stance remains that any use of cannabis—medical or otherwise—makes you an "unlawful user" under 18 U.S.C. § 922(g)(3).
2. The ATF and Form 4473 Until the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) updates its guidance or Congress amends the Gun Control Act, the question on Form 4473 regarding controlled substance use still lists marijuana as a disqualifier. The reclassification to Schedule III makes the federal government’s legal argument for a total ban weaker, but it has not yet removed the administrative barrier for patients.
3. The Supreme Court: United States v. Hemani (2026) The most definitive resolution for patients may not come from rescheduling, but from the courtroom. On March 2, 2026, the U.S. Supreme Court heard oral arguments in United States v. Hemani. This case directly challenges whether disarming a person solely for being a cannabis user—without any evidence of present intoxication or dangerous conduct—violates the Second Amendment.
With a final decision expected by June 2026, the legal community is watching closely. A favorable ruling in Hemani would do more to permanently protect your 2A rights than the Schedule III move alone.
Navigating the Legal Inequity
Unfortunately patients are being forced to walk a legal tightrope between their health and their constitutional rights. Currently, a person can be prescribed high-dose opioids or consume alcohol daily without jeopardizing their Second Amendment rights, yet a medical cannabis patient is still treated as a "prohibited person" by the federal government. This double standard highlights a significant gap in how we treat cannabis as legitimate medicine.
